Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)
EIPICO acquires 9.77% of the shares of the Medical Union Pharmaceuticals Company

Dr. Ahmed Kelani, Chairman of the Board of Directors and Managing Director of the Egyptian International Pharmaceutical Industries Company (EIPICO) announced that within the framework of EIPICO’s plan to increase its investments in the pharmaceutical industry and in full coordination with ACDIMA - EIPICO’s main shareholder…

On Thursday, December 19, 2019, EIPICO purchased 4,780 million shares for L.E. 210,320 million, an acquisition representing 9.77% of the Medical Union Pharmaceuticals (MUP) Company shares.
 
This comes in accordance with the decision made by the Board of Directors of EIPICO on June 25, 2019, of starting the acquisition process and addressing all concerned parties to obtain the necessary approvals, for the purchase of "EgyLease", the financial leasing company, share of the "Medical Union Pharmaceuticals" Company, within the framework of the former’s exit from the pharmaceutical sector.

Dr. Kelani added that the decision of acquisition was based on the good position of the Medical Union Pharmaceuticals Company in the Egyptian market nowadays and its ambitious plans to grow its local sales, export sales and profits in the future. 

Dr. Kelani concluded that this acquisition supports cooperation between the two sister companies (EIPICO and MUP), through using available resources of both companies, with the aim of offering best methods for the continuous availability - as much as possible - of their medicines, whether for the local market or for export, which is the strategic goal for ACDIMA, the country’s powerful provider of medicines.

December 25th, 2019






WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1427813